Abstract: The present invention provides compositions and methods for the prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases, for stimulating an immune response in a subject, and for use as an alternative to interleukin-12 (IL-12) treatment. In particular, the present invention provides Apicomplexa-related proteins (ARPs) that have immune stimulatory activity and thus have uses in the treatment and prevention of cancer and infectious diseases and in immune modulation. Compositions comprising an ARP are provided. Methods of use of an ARP for the prevention and/or treatment of cancer and/or infectious diseases, for use as an alternative to interleukin-12 (IL-12) treatment, and for eliciting an immune response in a subject, are also provided.

Abstract: A CPAP system and method which allows the control of released gases from the patient circuit. Coordination of blower speeds and the amount of released gases to improve patient therapy are disclosed. Methods and systems to control patient CO2 retention within the patient mask and to measure patient metabolic function are disclosed.

Abstract: The present invention provides compositions and methods for the prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases, for stimulating an immune response in a subject, and for use as an alternative to interleukin-12 (IL-12) treatment. In particular, the present invention provides Apicomplexa-related proteins (ARPs) that have immune stimulatory activity and thus have uses in the treatment and prevention of cancer and infectious diseases and in immune modulation. Compositions comprising an ARP are provided. Methods of use of an ARP for the prevention and/or treatment of cancer and/or infectious diseases, for use as an alternative to interleukin-12 (IL-12) treatment, and for eliciting an immune response in a subject, are also provided.

Abstract: The present invention provides compositions and methods for the prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases, for stimulating an immune response in a subject, and for use as an alternative to interleukin-12 (IL-12) treatment. In particular, the present invention provides Apicomplexa-related proteins (ARPs) that have immune stimulatory activity and thus have uses in the treatment and prevention of cancer and infectious diseases and in immune modulation. Compositions comprising an ARP are provided. Methods of use of an ARP for the prevention and/or treatment of cancer and/or infectious diseases, for use as an alternative to interleukin-12 (IL-12) treatment, and for eliciting an immune response in a subject, are also provided.

Abstract: At least some of the illustrative embodiments are hose systems for use with a positive airway pressure device comprising a first hose configured to fluidly couple on a device end to a first outlet of the positive airway pressure device and on a patient end to a first naris of a patient, and a second hose configured to fluidly couple on a device end to a second outlet of the positive airway pressure device and on a patient end to a second naris of the patient (wherein the second hose is fluidly independent from the first hose). The hose system is configured such that the first hose only couples to the first outlet and the second hose only couples to the second outlet.

Abstract: At least some of the illustrative embodiments are a humidifier system comprising an outer housing defining an internal volume, a dividing member within the internal volume that divides the internal volume into a first chamber and a second chamber (the first and second chambers fluidly independent of each other), a first inlet port and first outlet port (the first inlet and outlet ports in fluid communication with the first chamber), and second inlet port and a second outlet port (the second inlet and outlet ports in fluid communication with the second chamber).

Abstract: A method and system of coordinating an intensifier and sieve beds. At least some of the illustrative embodiments are methods comprising coordinating control of an intensifier with cycles of a sieve bed fluidly coupled to the intensifier such that there is at least one low pressure stroke of the intensifier and at least one high pressure stroke of the intensifier during a fill cycle of the sieve bed.

Abstract: A method and system of operating a trans-fill device. At least some of the illustrative embodiments are methods comprising generating an enriched gas stream from atmospheric air, and operating an intensifier which, when provided the enriched gas stream, produces a cylinder fill gas stream. The operating continues in the absence of the enriched gas stream being provided to the intensifier.

Abstract: A method and system of continuous flow selective delivery. At least some of the illustrative embodiments are methods comprising sensing an attribute of respiratory airflow of a first breathing orifice of a patient, and delivering a continuous flow of therapeutic gas to a second breathing orifice of the patient simultaneously with the sensing.

Abstract: An improved nasal cannula. Some illustrative embodiments are a cannula comprising a first nasal tube having a device end and an aperture end (wherein the cannula is configured to place the aperture end in fluid communication with the first naris of a patient), a second nasal tubing having a device end and an aperture end (wherein the cannula is configured to place the aperture end of the second nasal tubing in fluid communication with a second naris of the patient), and an oral tubing having a device end and an aperture end, and the oral tubing mechanically coupled to at least one of the first or second nasal tubing (wherein the cannula is configured to place the aperture end of the oral tubing in fluid communication with the mouth of a patient). The first nasal tubing, the second nasal tubing and the oral tubing are fluidly independent between their aperture ends and their device ends.

Abstract: The present invention provides compositions and methods for the prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases, for stimulating an immune response in a subject, and for use as an alternative to interleukin-12 (IL-12) treatment. In particular, the present invention provides Apicomlexa-related proteins (ARPs) that have immune stimulatory activity and thus have uses in the treatment and prevention of cancer and infectious diseases and in immune modulation. Compositions comprising an ARP are provided. Methods of use of an ARP for the prevention and/or treatment of cancer and/or infectious diseases, for use as an alternative to interleukin-12 (IL-12) treatment, and for eliciting an immune response in a subject, are also provided.